China Orthopedic Regenerative Surgical Products Market Size & Outlook

The orthopedic regenerative surgical products market in China is expected to reach a projected revenue of US$ 373.8 million by 2030. A compound annual growth rate of 5.4% is expected of China orthopedic regenerative surgical products market from 2023 to 2030.
Revenue, 2022 (US$M)
$245.7
Forecast, 2030 (US$M)
$373.8
CAGR, 2023 - 2030
5.4%
Report Coverage
China

China orthopedic regenerative surgical products market highlights

  • The China orthopedic regenerative surgical products market generated a revenue of USD 245.7 million in 2022 and is expected to reach USD 373.8 million by 2030.
  • The China market is expected to grow at a CAGR of 5.4% from 2023 to 2030.
  • In terms of segment, viscosupplements was the largest revenue generating product in 2022.
  • Allografts is the most lucrative product segment registering the fastest growth during the forecast period.


Orthopedic regenerative surgical products market data book summary

Market revenue in 2022USD 245.7 million
Market revenue in 2030USD 373.8 million
Growth rate5.4% (CAGR from 2022 to 2030)
Largest segmentViscosupplements
Fastest growing segmentAllografts
Historical data2016 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAllografts, Synthetic, Cell-based, Viscosupplements
Key market players worldwideAnika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen


Other key industry trends

  • In terms of revenue, China accounted for 5.9% of the global orthopedic regenerative surgical products market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan orthopedic regenerative surgical products market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 137.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Orthopedic Regenerative Surgical Products Market Scope

Orthopedic Regenerative Surgical Products Market Companies

Name Profile # Employees HQ Website

China orthopedic regenerative surgical products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.


Viscosupplements was the largest segment with a revenue share of 50.18% in 2022. Horizon Databook has segmented the China orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.


Research has also specified that obesity increases one’s risk of developing osteoarthritis later in life. The country has one of the highest numbers of overweight people, and obesity is a major public health concern. Thus, incidence of orthopedic conditions, such as osteoarthritis, is expected to increase over the forecast period owing to the aforementioned factors.

In January 2018, Vericel Corporation collaborated with Innovative Cellular Therapeutics (ICT) in China to develop and distribute MACI & other Vericel products in South Korea, Singapore, Greater China, and other countries in the region. Such initiatives are expected to support growth of the country’s market during the forecast period.

Reasons to subscribe to China orthopedic regenerative surgical products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China orthopedic regenerative surgical products market databook

  • Our clientele includes a mix of orthopedic regenerative surgical products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into China orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China orthopedic regenerative surgical products market size, by product, 2016-2030 (US$M)

China Orthopedic Regenerative Surgical Products Market Outlook Share, 2022 & 2030 (US$M)

China orthopedic regenerative surgical products market size, by product, 2016-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more